Sun Pharma Advance Research Co. (SPARC), a research wing of Sun Pharmaceuticals Industries, has suffered another set back during the fourth quarter ended March 2018 and its net sales declined sharply by 52
Original Article: SPARC revenues decline sharply by 52% in Q4